PATHOLOGICAL CHANGES IN MICE TREATED WITH CYCLOPHOSPHAMIDE AND EXOGENOUS DNA
The synergic action of the cytostatic drug cyclophosphamide (CP) and fragmented exogenous DNA causes illness and death in mice (Dolgova et al., 2011–2013). The observed «delayed death» effect was most clearly pronounced when the DNA preparation was administered 18 to 30 hours after CP treatment. Thi...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders
2014-12-01
|
| Series: | Вавиловский журнал генетики и селекции |
| Subjects: | |
| Online Access: | https://vavilov.elpub.ru/jour/article/view/120 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832575313698095104 |
|---|---|
| author | E. V. Dolgova V. P. Nikolin N. A. Popova A. S. Proskurina K. E. Orishchenko E. A. Alyamkina Ya. R. Efremov S. I. Baiborodin E. R. Chernykh A. A. Ostanin S. S. Bogachev T. S. Gvozdeva E. M. Malkova O. S. Taranov V. A. Rogachev A. S. Panov S. N. Zagrebelnyi M. A. Shurdov |
| author_facet | E. V. Dolgova V. P. Nikolin N. A. Popova A. S. Proskurina K. E. Orishchenko E. A. Alyamkina Ya. R. Efremov S. I. Baiborodin E. R. Chernykh A. A. Ostanin S. S. Bogachev T. S. Gvozdeva E. M. Malkova O. S. Taranov V. A. Rogachev A. S. Panov S. N. Zagrebelnyi M. A. Shurdov |
| author_sort | E. V. Dolgova |
| collection | DOAJ |
| description | The synergic action of the cytostatic drug cyclophosphamide (CP) and fragmented exogenous DNA causes illness and death in mice (Dolgova et al., 2011–2013). The observed «delayed death» effect was most clearly pronounced when the DNA preparation was administered 18 to 30 hours after CP treatment. This time span is designated as «death window».It was found that injections of exogenous DNA result in sustained increase in bone marrow cell (BMC) apoptosis, which occurs throughout the time of DNA administration (18–30 hours). Exogenous DNA, both allogeneic and belonging to various taxa induces BMCs apoptosis. Plasmid DNA has the greatest effect on apoptosis induction.The analysis of reduction and restoration of BMC subpopulations as the mice progressed to death revealed a virtually complete loss of the 12–20-mkm fraction of the cell population (about 3–4 % vs. 35–40 % in the control), which corresponds to the maximum leukopenia on day 3 after CP treatment. However, the relative amount of CD34+ hematopoietic stem cells (HSCs) from day 15 and till the end of the observation constituted 1,2–1,4 %, which corresponds to the wild-type range. Comparison of BMC smears from the sternal bone marrow of the CP and CP+DNA groups of mice indicates that the BMC populations isolated from CP+DNA animals lack young committed lymphopoiesis progenitor cells. Moreover, the affected mice had immature blast cell types in their blood, which was never observed in healthy or CP-treated mice. Pathological and morphological analyses show that starting from posttreatment day 9, mice that received CP+DNA preparations displayed pronounced morphological changes in their lungs, liver, pancreas, central and peripheral immune system organs, and brain. Most of the pathological changes observed are consistent with severe inflammatory response. This suggestion is proven by structural equivalents of functional involution of lymphoid organs, such as thymus, spleen, and lymph nodes.We speculate that the death of treated animals resulted from multiple organ dysfunctions caused by accidental involution of lymphoid organs and the systemic inflammatory response syndrome, both associated with injections of fragmented exogenous DNA into experimental animals within the «death window», which corresponds to the final step in the repair of the majority of CP-induced double-strand breaks. |
| format | Article |
| id | doaj-art-8a8485cb8bd04035b5de9e6b8ffe1a6a |
| institution | Kabale University |
| issn | 2500-3259 |
| language | English |
| publishDate | 2014-12-01 |
| publisher | Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders |
| record_format | Article |
| series | Вавиловский журнал генетики и селекции |
| spelling | doaj-art-8a8485cb8bd04035b5de9e6b8ffe1a6a2025-02-01T09:57:59ZengSiberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and BreedersВавиловский журнал генетики и селекции2500-32592014-12-01171129146104PATHOLOGICAL CHANGES IN MICE TREATED WITH CYCLOPHOSPHAMIDE AND EXOGENOUS DNAE. V. Dolgova0V. P. Nikolin1N. A. Popova2A. S. Proskurina3K. E. Orishchenko4E. A. Alyamkina5Ya. R. Efremov6S. I. Baiborodin7E. R. Chernykh8A. A. Ostanin9S. S. Bogachev10T. S. Gvozdeva11E. M. Malkova12O. S. Taranov13V. A. Rogachev14A. S. Panov15S. N. Zagrebelnyi16M. A. Shurdov17Institute of Cytology and Genetics SB RAS, Novosibirsk, RussiaInstitute of Cytology and Genetics SB RAS, Novosibirsk, RussiaInstitute of Cytology and Genetics SB RAS, Novosibirsk, RussiaInstitute of Cytology and Genetics SB RAS, Novosibirsk, RussiaInstitute of Cytology and Genetics SB RAS, Novosibirsk, RussiaInstitute of Cytology and Genetics SB RAS, Novosibirsk, RussiaInstitute of Cytology and Genetics SB RAS, Novosibirsk, RussiaInstitute of Cytology and Genetics SB RAS, Novosibirsk, RussiaInstitute of Clinical Immunology SB RAMS, Novosibirsk, RussiaInstitute of Clinical Immunology SB RAMS, Novosibirsk, RussiaInstitute of Cytology and Genetics SB RAS, Novosibirsk, RussiaNovosibirsk State Medical University, Novosibirsk, RussiaResearch Center for Virology and Biotechnology Vector, Koltsovo, RussiaResearch Center for Virology and Biotechnology Vector, Koltsovo, RussiaInstitute of Cytology and Genetics SB RAS, Novosibirsk, RussiaWellsStar College of Health & Human Services, Kennesaw State University Kennesaw, Georgia, USANovosibirsk National Research State University, Novosibirsk, RussiaООО Panagen, Gorno-Altaysk, RussiaThe synergic action of the cytostatic drug cyclophosphamide (CP) and fragmented exogenous DNA causes illness and death in mice (Dolgova et al., 2011–2013). The observed «delayed death» effect was most clearly pronounced when the DNA preparation was administered 18 to 30 hours after CP treatment. This time span is designated as «death window».It was found that injections of exogenous DNA result in sustained increase in bone marrow cell (BMC) apoptosis, which occurs throughout the time of DNA administration (18–30 hours). Exogenous DNA, both allogeneic and belonging to various taxa induces BMCs apoptosis. Plasmid DNA has the greatest effect on apoptosis induction.The analysis of reduction and restoration of BMC subpopulations as the mice progressed to death revealed a virtually complete loss of the 12–20-mkm fraction of the cell population (about 3–4 % vs. 35–40 % in the control), which corresponds to the maximum leukopenia on day 3 after CP treatment. However, the relative amount of CD34+ hematopoietic stem cells (HSCs) from day 15 and till the end of the observation constituted 1,2–1,4 %, which corresponds to the wild-type range. Comparison of BMC smears from the sternal bone marrow of the CP and CP+DNA groups of mice indicates that the BMC populations isolated from CP+DNA animals lack young committed lymphopoiesis progenitor cells. Moreover, the affected mice had immature blast cell types in their blood, which was never observed in healthy or CP-treated mice. Pathological and morphological analyses show that starting from posttreatment day 9, mice that received CP+DNA preparations displayed pronounced morphological changes in their lungs, liver, pancreas, central and peripheral immune system organs, and brain. Most of the pathological changes observed are consistent with severe inflammatory response. This suggestion is proven by structural equivalents of functional involution of lymphoid organs, such as thymus, spleen, and lymph nodes.We speculate that the death of treated animals resulted from multiple organ dysfunctions caused by accidental involution of lymphoid organs and the systemic inflammatory response syndrome, both associated with injections of fragmented exogenous DNA into experimental animals within the «death window», which corresponds to the final step in the repair of the majority of CP-induced double-strand breaks.https://vavilov.elpub.ru/jour/article/view/120cyclophosphamideexogenous dnabone marrow cellsapoptosissystemic inflammationaccidental involution of lymphoid organs |
| spellingShingle | E. V. Dolgova V. P. Nikolin N. A. Popova A. S. Proskurina K. E. Orishchenko E. A. Alyamkina Ya. R. Efremov S. I. Baiborodin E. R. Chernykh A. A. Ostanin S. S. Bogachev T. S. Gvozdeva E. M. Malkova O. S. Taranov V. A. Rogachev A. S. Panov S. N. Zagrebelnyi M. A. Shurdov PATHOLOGICAL CHANGES IN MICE TREATED WITH CYCLOPHOSPHAMIDE AND EXOGENOUS DNA Вавиловский журнал генетики и селекции cyclophosphamide exogenous dna bone marrow cells apoptosis systemic inflammation accidental involution of lymphoid organs |
| title | PATHOLOGICAL CHANGES IN MICE TREATED WITH CYCLOPHOSPHAMIDE AND EXOGENOUS DNA |
| title_full | PATHOLOGICAL CHANGES IN MICE TREATED WITH CYCLOPHOSPHAMIDE AND EXOGENOUS DNA |
| title_fullStr | PATHOLOGICAL CHANGES IN MICE TREATED WITH CYCLOPHOSPHAMIDE AND EXOGENOUS DNA |
| title_full_unstemmed | PATHOLOGICAL CHANGES IN MICE TREATED WITH CYCLOPHOSPHAMIDE AND EXOGENOUS DNA |
| title_short | PATHOLOGICAL CHANGES IN MICE TREATED WITH CYCLOPHOSPHAMIDE AND EXOGENOUS DNA |
| title_sort | pathological changes in mice treated with cyclophosphamide and exogenous dna |
| topic | cyclophosphamide exogenous dna bone marrow cells apoptosis systemic inflammation accidental involution of lymphoid organs |
| url | https://vavilov.elpub.ru/jour/article/view/120 |
| work_keys_str_mv | AT evdolgova pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT vpnikolin pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT napopova pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT asproskurina pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT keorishchenko pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT eaalyamkina pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT yarefremov pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT sibaiborodin pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT erchernykh pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT aaostanin pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT ssbogachev pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT tsgvozdeva pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT emmalkova pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT ostaranov pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT varogachev pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT aspanov pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT snzagrebelnyi pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna AT mashurdov pathologicalchangesinmicetreatedwithcyclophosphamideandexogenousdna |